You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

60 Results
Guidelines and Advice
Status: Current
ID: MCC
Jun 2006
Guidelines and Advice
Aug 2006
Guidelines and Advice
Status: Current
ID: 4-16
Version: 3
May 2025
Guidelines and Advice
May 2006
Guidelines and Advice
Guidelines and Advice
Guidelines and Advice
Apr 2006
Guidelines and Advice
Status: Current
ID: GL-C50-03
Apr 2006
Statistical Reports
Drug
Other Name(s): Lupron® , Lupron Depot® , Eligard®
May 2025
Regimen
Cancer Type:
Genitourinary, 
Prostate
Intent: Neoadjuvant, Adjuvant, Palliative
Funding:
ODB - General Benefit
    leuprolide - long-acting formulation
May 2025

Pages